You are here

Article info

Article menu
Download PDFPDF
Colorectal
Review
Use of anti-TNF drug levels to optimise patient management

Authors

  • Konstantinos Papamichael Division of Gastroenterology, Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Adam S Cheifetz Division of Gastroenterology, Center for Inflammatory Bowel Diseases, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Adam S Cheifetz, Division of Gastroenterology, Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., Rabb 425, Boston, MA 02215, USA; acheifet{at}bidmc.harvard.edu
View Full Text

Citation

Papamichael K, Cheifetz AS
Use of anti-TNF drug levels to optimise patient management
Frontline Gastroenterology 2016;7:289-300.

Publication history

  • Received January 10, 2016
  • Accepted January 23, 2016
  • First published February 26, 2016.
Online issue publication 
September 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/